# PemVin vs Vin in Previously Treated Metastatic Breast Cancer

> **NCT03242616** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 17 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** Pemetrexed + Vinorelbine
- **DRUG:** Vinorelbine

## Key facts

- **NCT ID:** NCT03242616
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-17
- **Primary completion:** 2023-12-05
- **Final completion:** 2024-04-15
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03242616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03242616, "PemVin vs Vin in Previously Treated Metastatic Breast Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03242616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*